Pages

▼
Monday, February 29, 2016

Results from a Phase-II Dual Stem Cell Trial

›
Back in 2011, when this clinical trial was registered, I was not careful about blogging on all the new research.  Somehow I completely misse...
1 comment:
Wednesday, February 17, 2016

Alefacept Reports on Phase-II Results

›
Alefacept is a drug that has been used to treat the skin condition, psoriasis. Psoriasis is generally considered to be an autoimmune disea...
1 comment:
Sunday, January 31, 2016

Research In The News (January)

›
These are a couple of old news items that I'm catching up with. Kamada Changes Phase-II Alpha-1 Antitrypsin (AAT) Study Kamada has an...
2 comments:
Friday, January 22, 2016

Exsulin / Ustekinumab Combo Starts Phase-I Clinical Trial

›
Exsulin is a drug designed to trigger beta cell growth and Ustekinumab is designed to modulate the immune system.  These researchers are te...
Sunday, November 29, 2015

Tauroursodeoxycholic Acid (TUDCA) Starts a Phase-I Trial

›
Tauroursodeoxycholic Acid (also known as TUDCA or Taurolite) is a chemical found in bile (especially bear bile).  Mouse and rat studies have...
2 comments:
Saturday, November 21, 2015

Perle Biosciences Starts a Phase-II Trial Of A Combo Cure

›
This turned out to be a much longer blog posting than I expected.  Lots of interesting digressions and complexities. Perle Biosciences is ...
5 comments:
Saturday, November 14, 2015

Research In The News (November)

›
MK-2640 ("Smart Insulin") Completes Enrollment Collection of a Phase-I Clinical Trial And Then Adds a New Part MK-2640 is the M...
2 comments: